GlaxoSmithKline PLC Director/PDMR Shareholding (0523S)
November 01 2019 - 01:19PM
UK Regulatory
TIDMGSK
RNS Number : 0523S
GlaxoSmithKline PLC
01 November 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=======================================================================
a) Name Ms E Walmsley
=== ======================== =============================================
b) Position/status Chief Executive Officer
=== ======================== =============================================
c) Initial notification/ Initial notification
amendment
=== ======================== =============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =======================================================================
a) Name GlaxoSmithKline plc
=== ======================== =============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== =============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== =============================================
b) Nature of the The exercise of options over 137,040 Ordinary
transaction Shares, granted on 22 July 2010 under the
GlaxoSmithKline 2009 Share Option Plan.
=== ======================== =============================================
c) Price(s) and Price(s) Volume(s)
volume(s) GBP12.035 137,040
----------
=== ======================== =============================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ======================== =============================================
e) Date of the transaction 2019-10-31
=== ======================== =============================================
f) Place of the N/A
transaction
=== ======================== =============================================
1. Details of PDMR/person closely associated with them
('PCA')
======================================================================
a) Name Ms E Walmsley
=== ======================== ============================================
b) Position/status Chief Executive Officer
=== ======================== ============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ======================== ============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ============================================
b) Nature of the The sale of 112,945 Ordinary Shares to
transaction cover the tax and cost of exercise of the
options granted on 22 July 2010 under the
GlaxoSmithKline 2009 Share Option Plan.
=== ======================== ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) GBP17.7588 112,945
----------
=== ======================== ============================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ======================== ============================================
e) Date of the transaction 2019-10-31
=== ======================== ============================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ============================================
1. Details of PDMR/person closely associated with them
('PCA')
==========================================================================================
a) Name Ms E Walmsley
==== ====================================== ==================================================
b) Position/status Chief Executive Officer
==== ====================================== ==================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ==================================================
b) Nature of the Transfer of 24,095 Ordinary Shares to
transaction spouse for nil consideration.
==== ====================================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ======================= ======================
GBP0.00 24,095
=================================================================== ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================ =============================
e) Date of the transaction 2019-10-31
==== ====================================== ==================================================
f) Place of the transaction N/A
====================================== ==================================================
Details of PDMR/person closely associated with them
('PCA')
==========================================================================================
a) Name Mr David Owen
==== ====================================== ==================================================
b) Position/status PCA of Ms E Walmsley (Chief Executive
Officer)
==== ====================================== ==================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ==================================================
b) Nature of the Receipt of 24,095 Ordinary Shares from
transaction spouse for nil consideration.
==== ====================================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ======================= ======================
GBP0.00 24,095
=================================================================== ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================ =============================
e) Date of the transaction 2019-10-31
==== ====================================== ==================================================
f) Place of the transaction N/A
====================================== ==================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHDFLFBKFFFFBE
(END) Dow Jones Newswires
November 01, 2019 13:19 ET (17:19 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Feb 2024 to Mar 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2023 to Mar 2024